QCG
BLFS icon

Quadrant Capital Group’s BioLife Solutions BLFS Stock Holding History

Quadrant Capital Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-323
Closed -$7.38K – 1506
2025
Q1 		$7.38K Buy
323
+186
+136% +$4.9K ﹤0.01% 2275
2024
Q4 		$3.56K Hold
137
– – ﹤0.01% 2385
2024
Q3 		$3.43K Buy
137
+68
+99% +$1.61K ﹤0.01% 2393
2024
Q2 		$1.48K Sell
69
-132
-66% -$2.56K ﹤0.01% 2518
2024
Q1 		$3.73K Buy
+201
New +$3.52K ﹤0.01% 2383
2023
Q4 		– Sell
-122
Closed -$1.69K – 2702
2023
Q3 		$1.69K Sell
122
-20
-14% -$315 ﹤0.01% 2432
2023
Q2 		$3.14K Sell
142
-895
-86% -$18.9K ﹤0.01% 2314
2023
Q1 		$22.6K Buy
1,037
+881
+565% +$19.8K ﹤0.01% 1638
2022
Q4 		$2.84K Sell
156
-82
-34% -$1.69K ﹤0.01% 2328
2022
Q3 		$5K Buy
238
+91
+62% +$1.95K ﹤0.01% 2122
2022
Q2 		$2K Buy
+147
New +$2.16K ﹤0.01% 2184

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Quadrant Capital Group's BLFS Position: Q2 2025 in Review

Quadrant Capital Group sold out of BioLife Solutions (BLFS) in Q2 2025, closing a stake of 323 shares — an estimated $7.38K sold.

Quadrant Capital Group first reported a position in BLFS in Q2 2022 and held it in 11 quarters. The position peaked at $22.6K in Q1 2023. 194 funds tracked by Wall St. Rank hold BLFS as of Q2 2025.

  • Quadrant Capital Group reported no remaining BioLife Solutions position as of Q2 2025 after selling out during the quarter.
  • Quadrant Capital Group sold 323 BioLife Solutions shares in Q2 2025, an estimated $7.38K.
  • Quadrant Capital Group first reported a position in BioLife Solutions in Q2 2022 and held it in 11 quarters.
  • Quadrant Capital Group's BioLife Solutions position peaked at $22.6K in Q1 2023.
  • 194 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2025.

Based on Quadrant Capital Group's 13F filing for Q2 2025, filed 13 Aug 2025.